Photocatalytic degradation of lomefloxacin antibiotics using hydrothermally synthesized magnesium titanate under visible light-driven energy sources

Antibiotics in water system pose a human health risk due to the rise of antibacterial activity in the environmental web. Advanced oxidation processes are the potential to become an effective treatment technology for targeting antibiotics. This study demonstrates the visible light photocatalysis of lomefloxacin using magnesium titanate (MgTiO3). The nanomaterial was subjected to computational analysis to study morphology, functional, and optical characteristics through FESEM, XRD, FTIR, BET, UV-Vis, etc. Importantly, MgTiO3 had band gap energy of 3.09 eV. The photocatalytic studies were performed to observe different parameters affecting lomefloxacin degradation such as initial concentration, catalyst dosage, and pH. The nanomaterial exhibited the maximum lomefloxacin degradation. The study revealed that 30 mg/L of catalyst was optimum to degrade 10 mg/L of lomefloxacin with 30-W LED irradiation up to 150 min. Reactive species, namely, electron, hole, hydroxyl, and superoxide radicals, comprised the primary photocatalytic mechanism for lomefloxacin degradation. Ultimately, the summative result from this study highlights the suitability of the photocatalytic system to treat persistent antibiotics in aqueous environment.

Automated summary

This study investigates the visible light photocatalysis of lomefloxacin using magnesium titanate. The nanomaterial exhibited high efficiency in degrading lomefloxacin under specific conditions, and its morphology, functional, and optical characteristics were analyzed through computational analysis. The findings suggest that using a photocatalytic system for treating antibiotics in aqueous environments is feasible.